Results 201 to 210 of about 96,603 (330)

Benign prostatic hyperplasia‐associated prostate‐specific antigen (BPSA) shows unique immunoreactivity with anti‐PSA monoclonal antibodies [PDF]

open access: bronze, 2000
Tang J. Wang   +4 more
openalex   +1 more source

Natural Products Targeting the EGFR/HER2 Axis in Tumorigenesis: Interpretation of Molecular Mechanisms and Recent Insights Into Synergistic Strategies for Cancer Therapy

open access: yesFood Frontiers, Volume 7, Issue 1, January 2026.
Schematic overview illustrating the anticancer mechanisms of selected natural products (resveratrol, quercetin, berberine) targeting EGFR and HER2 signaling pathways in tumor cells. These compounds inhibit receptor activation and downstream oncogenic cascades, including PI3K/Akt/mTOR, MAPK/ERK, and STAT3 pathways.
Iman Ramli   +8 more
wiley   +1 more source

Cu–Mn BimetallicMesoporous Silica NanosonosensitizersEnable Oxeiptosis-Mediated Sonodynamic Therapy for Ultra-MinimallyInvasive Treatment of Benign Prostatic Hyperplasia

open access: green
Mingyu Chang (22189749)   +13 more
openalex   +1 more source

Natural Products Targeting Notch Signaling in Cancer: Mechanistic Insights and Food‐Based Chemoprevention Potential

open access: yesFood Frontiers, Volume 7, Issue 1, January 2026.
The Notch signaling pathway plays a dual role in cancer, acting as both a tumor promoter and suppressor depending on cellular context. This review highlights how natural products modulate Notch signaling to inhibit tumor initiation, progression, angiogenesis, and cancer stem cell maintenance.
Rabab Fatima   +15 more
wiley   +1 more source

Incidentally Detected Ductal Adenocarcinoma Presenting With Isolated Pulmonary Metastasis and a BRCA2 Mutation

open access: yesIJU Case Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background Ductal adenocarcinoma of the prostate is a rare and aggressive cancer that often presents with low prostate‐specific antigen levels and nonspecific urinary symptoms, leading to a delayed diagnosis. Mutations in DNA repair genes such as BRCA2 may render these cancers susceptible to targeted treatments. Case Presentation A 78‐year‐old
Hiroyuki Karasawa   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy